Literature DB >> 22057788

Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with loss of morphological but retained genetic key features during progression.

Adelheid Woehrer, Irene Slavc, Andreas Peyrl, Thomas Czech, Christian Dorfer, Daniela Prayer, Susanne Stary, Berthold Streubel, Marina Ryzhova, Andrey Korshunov, Stefan M Pfister, Christine Haberler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22057788     DOI： 10.1007/s00401-011-0903-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  10 in total

1.  CT and Multimodal MR Imaging Features of Embryonal Tumors with Multilayered Rosettes in Children.

Authors:  V Dangouloff-Ros; A Tauziède-Espariat; C-J Roux; R Levy; D Grévent; F Brunelle; A Gareton; S Puget; K Beccaria; T Blauwblomme; J Grill; C Dufour; P Varlet; N Boddaert
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

2.  Embryonal tumor with multilayered rosettes, C19MC-altered (ETMR): a newly defined pediatric brain tumor.

Authors:  Yu-Chun Pei; Guo-Hao Huang; Xiao-Hong Yao; Xiu-Wu Bian; Fei Li; Yan Xiang; Lin Yang; Sheng-Qing Lv; Jun Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

Review 3.  Evaluation of the good tumor response of embryonal tumor with abundant neuropil and true rosettes (ETANTR).

Authors:  Petra Mozes; Péter Hauser; Tibor Hortobágyi; Gábor Benyó; István Peták; Miklós Garami; Adrienne Cserháti; Katalin Bartyik; László Bognár; Zoltán Nagy; Eszter Turányi; Katalin Hideghéty
Journal:  J Neurooncol       Date:  2015-09-15       Impact factor: 4.130

Review 4.  Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features.

Authors:  C Dunham
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

5.  Long-term survival in a case of ETANTR with histological features of neuronal maturation after therapy.

Authors:  Manila Antonelli; Andrey Korshunov; Angela Mastronuzzi; Francesca Diomedi Camassei; Andrea Carai; Giovanna S Colafati; Stefan M Pfister; Marcel Kool; Felice Giangaspero
Journal:  Virchows Arch       Date:  2015-02-20       Impact factor: 4.064

6.  Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry).

Authors:  Lucy Gately; Katharine Drummond; Mark Rosenthal; Rosemary Harrup; Anthony Dowling; Andrew Gogos; Zarnie Lwin; Ian Collins; David Campbell; Elizabeth Ahern; Claire Phillips; Hui K Gan; Iwan Bennett; Oliver M Sieber; Peter Gibbs
Journal:  BMC Cancer       Date:  2022-06-02       Impact factor: 4.638

7.  LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).

Authors:  Andrey Korshunov; Marina Ryzhova; David T W Jones; Paul A Northcott; Peter van Sluis; Richard Volckmann; Jan Koster; Rogier Versteeg; Cynthia Cowdrey; Arie Perry; Daniel Picard; Marc Rosenblum; Felice Giangaspero; Eleonora Aronica; Ulrich Schüller; Martin Hasselblatt; V Peter Collins; Andreas von Deimling; Peter Lichter; Annie Huang; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2012-11-16       Impact factor: 17.088

8.  Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.

Authors:  Andrey Korshunov; Dominik Sturm; Marina Ryzhova; Volker Hovestadt; Marco Gessi; David T W Jones; Marc Remke; Paul Northcott; Arie Perry; Daniel Picard; Marc Rosenblum; Manila Antonelli; Eleonora Aronica; Ulrich Schüller; Martin Hasselblatt; Adelheid Woehrer; Olga Zheludkova; Ella Kumirova; Stephanie Puget; Michael D Taylor; Felice Giangaspero; V Peter Collins; Andreas von Deimling; Peter Lichter; Annie Huang; Torsten Pietsch; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2013-12-14       Impact factor: 17.088

9.  Radiation for ETMR: Literature review and case series of patients treated with proton therapy.

Authors:  Sergio Jaramillo; David R Grosshans; Nancy Philip; Ali Varan; Canan Akyüz; Mary Frances McAleer; Anita Mahajan; Susan L McGovern
Journal:  Clin Transl Radiat Oncol       Date:  2018-11-07

10.  CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.

Authors:  Tara Spence; Patrick Sin-Chan; Daniel Picard; Mark Barszczyk; Katharina Hoss; Mei Lu; Seung-Ki Kim; Young-Shin Ra; Hideo Nakamura; Jason Fangusaro; Eugene Hwang; Erin Kiehna; Helen Toledano; Yin Wang; Qing Shi; Donna Johnston; Jean Michaud; Milena La Spina; Anna Maria Buccoliero; Dariusz Adamek; Sandra Camelo-Piragua; V Peter Collins; Chris Jones; Nabil Kabbara; Nawaf Jurdi; Pascale Varlet; Arie Perry; David Scharnhorst; Xing Fan; Karin M Muraszko; Charles G Eberhart; Ho-Keung Ng; Sridharan Gururangan; Timothy Van Meter; Marc Remke; Lucie Lafay-Cousin; Jennifer A Chan; Nongnuch Sirachainan; Scott L Pomeroy; Steven C Clifford; Amar Gajjar; Mary Shago; William Halliday; Michael D Taylor; Richard Grundy; Ching C Lau; Joanna Phillips; Eric Bouffet; Peter B Dirks; Cynthia E Hawkins; Annie Huang
Journal:  Acta Neuropathol       Date:  2014-05-20       Impact factor: 17.088
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.